SCHEMBL14909095

SCHEMBL14909095

COC(=O)c1cc(F)c(N(CCNC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)nc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.38
ACVR1B P36896 2/20 0.37
TGFBR1 P36897 2/20 0.37
ACVRL1 P37023 2/20 0.37
SUV39H2 Q9H5I1 2/20 0.36
STK17B O94768 1/20 0.36
STK17A Q9UEE5 1/20 0.36
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
MAPK3 P27361 1/20 0.35
PARP1 P09874 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
NQO2 P16083 1/20 0.34
TP53 P04637 1/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14911315 0.91 KEAP1 (0.40) ACVR1BTGFBR1ACVRL1SUV39H2STK17B
SCHEMBL14931090 0.90 GRM2 (0.36) ACVR1BTGFBR1ACVRL1SUV39H2STK17B
SCHEMBL14927585 0.88 ATR (0.36) ATRACVR1BTGFBR1ACVRL1ALDH1A1
SCHEMBL14910422 0.87 ATR (0.35) ATRACVR1BTGFBR1ACVRL1MAPT
SCHEMBL14923504 0.83 TRPA1 (0.36) SUV39H2STK17BSTK17ACKS1BSKP1
SCHEMBL14909331 0.82 CD38 (0.32) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL14910299 0.80 KDM4E (0.40) ATRALDH1A1HPGDMAPTMEN1
SCHEMBL3360033 0.78 STK17B (0.46) ATRACVR1BTGFBR1ACVRL1SUV39H2
SCHEMBL14927587 0.77 KEAP1 (0.45) CSNK2A1
SCHEMBL14923502 0.77 KEAP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK ATR 1155/4885ACVR1B 1016/4885TGFBR1 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.